Influenza - Pipeline Review, Q1 2011

Global Markets Direct
February 28, 2011
131 Pages - SKU: GMD6185846
Legionella Control (UK) - Industry Report
10/7/2014 | published by: Plimsoll Publishing Ltd.
Plimsoll’s UK Legionella Control (UK) analysis is the most definitive and accurate study of the UK Legionella Control (UK) sector in 2014. The report is split into two sections and uses both a written and graphical  |  read more...
USD 560
Biotechnology (Pharmaceuticals) (Global) - Industry Report
10/7/2014 | published by: Plimsoll Publishing Ltd.
Plimsoll’s Biotechnology (UK) analysis is the most definitive and accurate study of the Biotechnology (UK) sector in 2014. The report is split into two sections and uses both a written and graphical analysis – analysing the  |  read more...
USD 1,520
EpiCast Report: Allergic Conjunctivitis - Epidemiology Forecast to 2023
10/7/2014 | published by: GlobalData
EpiCast Report: Allergic Conjunctivitis - Epidemiology Forecast to 2023 Summary Allergic conjunctivitis is an inflammation of the eye resulting from an allergic reaction to allergy causing substances (external antigens) like pollen, dander, mold, or other substances. In  |  read more...
USD 3,995
KOL Insight: Multiple Sclerosis
10/6/2014 | published by: FirstWord
Introduction Recent launches of oral therapies have brought clinical advantages and clear patient benefits and are set to transform the treatment of Multiple Sclerosis (MS). The question is, which products will  |  read more...
USD 6,495
EpiCast Report: Dyslipidemia - Epidemiology Forecast to 2023
10/15/2014 | published by: GlobalData
Wind Power in Australia, Market Outlook to 2025, Update 2014 - Capacity, Generation, Levelized Cost of Energy (LCOE), Investment Trends, Regulations and Company Profiles Summary Wind Power in Australia, Market Outlook to 2025, Update 2014 - Capacity,  |  read more...
USD 3,995
Herpes Zoster (Shingles) - Pipeline Review, H2 2014
9/15/2014 | published by: Global Markets Direct
Herpes Zoster (Shingles) - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Herpes Zoster (Shingles) - Pipeline Review, H2 2014’, provides an overview of the Herpes Zoster (Shingles)’s therapeutic pipeline. This report provides comprehensive information on the therapeutic  |  read more...
USD 2,000
Hyperglycemia - Pipeline Review, H2 2014
9/15/2014 | published by: Global Markets Direct
Hyperglycemia - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Hyperglycemia - Pipeline Review, H2 2014’, provides an overview of the Hyperglycemia’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Hyperglycemia, complete with comparative  |  read more...
USD 2,000
Myocardial Ischemia Global Clinical Trials Review, H2, 2014
9/21/2014 | published by: GlobalData
Myocardial Ischemia Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Myocardial Ischemia Global Clinical Trials Review, H2, 2014 provides data on the Myocardial Ischemia clinical trial scenario. This report provides elemental information and data  |  read more...
USD 2,500
Cerebral Palsy - Pipeline Review, H2 2014
9/22/2014 | published by: Global Markets Direct
Cerebral Palsy - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Cerebral Palsy - Pipeline Review, H2 2014’, provides an overview of the Cerebral Palsy’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Cerebral  |  read more...
USD 2,000
Iron Deficiency Anemia - Pipeline Review, H2 2014
9/10/2014 | published by: Global Markets Direct
Iron Deficiency Anemia - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Iron Deficiency Anemia - Pipeline Review, H2 2014’, provides an overview of the Iron Deficiency Anemia’s therapeutic pipeline. This report provides comprehensive information on the therapeutic  |  read more...
USD 2,000
 

SELECT A LICENSE

    Online Download  USD 500  
    Global Site License  USD 1,500  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!